Vilket är priset för FluoroPharma Medical, Inc. (FPMI)

Priset för FluoroPharma Medical, Inc. (FPMI) är $0.0002

Vilket är marknadsvärdet för FluoroPharma Medical, Inc. (FPMI)

Marknadsvärdet för FluoroPharma Medical, Inc. (FPMI) är $6.85K

FluoroPharma Medical, Inc. (FPMI) Pris och Marknadsvärde

FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.

Pris för FPMI	Tillgång B	Marknadsvärdet för B	Resultat
$157,133 $6.85K	NVDA	$5.383T	+78,566,250,045.94%
$129,112 $6.85K	AAPL	$4.423T	+64,556,205,442.00%
$121,435 $6.85K	GOOG	$4.160T	+60,717,591,830.56%
$106,927 $6.85K	MSFT	$3.663T	+53,463,526,417.81%
$84,390.80 $6.85K	AMZN	$2.891T	+42,195,399,716.11%

Pris för FPMI

Tillgång B

Marknadsvärdet för B

Resultat

$157,133 $6.85K